Circulating Tumor DNA (ctDNA)
Circulating Tumor DNA (ctDNA): is tumor-derived fragmented DNA in the bloodstream that is not associated with cells.
MAY 14, 2020
6:40 PM EDT
MAY 14, 2020
6:40 PM EDT
Genomic profiling of liquid biopsies is no longer an emerging area of clinical research, but quickly becoming translated as part of contemporary clinical trials for potential future use in t...
APR 10, 2019
12:00 PM PDT
APR 10, 2019
12:00 PM PDT
Determining which patients would derive clinical benefit from immunotherapy is a compelling clinical question. Biomarkers have been shown to predict therapy outcome in various types of cancer...
FEB 23, 2017
12:00 PM PST
FEB 23, 2017
12:00 PM PST
Despite vast investment for decades in cancer research and development, cancer is still among the leading causes of death worldwide and its toll is expected to rise by about 70% over the next...
FEB 23, 2017
6:00 AM PST
FEB 23, 2017
6:00 AM PST
Liquid Biopsies are gaining acceptance in the Oncology community as a surrogate or complement to the gold standard of tissue biopsy. A liquid biopsy provides biomarker information that...
JAN 19, 2017
8:00 AM PST
JAN 19, 2017
8:00 AM PST
DATE: January 19th, 2017TIME: 8:00AM PT, 11:00AM ETLiquid biopsies have the potential to be a less invasive method than traditional biopsies to detect advanced solid tumor mutational st...
APR 06, 2016
6:00 AM PDT
APR 06, 2016
6:00 AM PDT
The advent of personalized medicine employing molecular targeted therapies has markedly changed the treatment of cancer in the past 10 years. Although tumor tissue biopsy-based genotyping is...